DEALS
-
-
Year
-
-
- Practices
-
Chinese Mainland Capital MarketsHong Kong & Overseas Capital MarketsInvestment/M&A & Corporate GovernanceCross-border Investment/M&AConstruction & Project DevelopmentFinancingDebt Restructuring & Non-performing AssetsTaxation & Wealth PlanningPrivate Equity & Investment FundsFinancial Products & TrustsLitigation & ArbitrationCorporate & Commercial CrimeBankruptcy, Insolvency & ReorganizationShippingCompliance & InvestigationAntitrust & CompetitionTrade Compliance & Trade RemediesCustoms & Import/ExportLabor & EmploymentHealth, Safety & Environmental ProtectionIP Licensing & EnforcementTrademark ProsecutionPatent ProsecutionCybersecurity & Data Protection
-
- Industries
-
Real EstateUrban InfrastructureTransportation & LogisticsTourism & HospitalityEnergy & PowerMining & Natural ResourcesBanking & Financial ServicesInsuranceFinancial Innovation & FintechTelecommunications & InternetInformation & Intelligence TechnologyHealthcarePharmaceuticals & Life SciencesEducation & TrainingMedia, Sports & EntertainmentNational Defense & Military IndustryRetail & Consumer ProductsIndustry & ManufacturingAgriculture & Food
-
- Latest
- Most relevant
-
-
-
Zhong Lun Advises on Everest Medicines’ IPO in Hong Kong
As Everest Medicines Limited’s long-term legal counsel, Zhong Lun Law Firm had provided legal services for its incubation and inception, every round of financing, merger and restructuring, and acted as its PRC legal advisor in this offering.
2020-10-09
-
- 2020-09-30
-
Zhong Lun Advised Nucarf on Strategic Acquisition and PE Financing
Zhong Lun Law Firm acted as the legal counsel and provided cross-border legal services to Nucarf on both acquisition and financing.
-
- 2020-09-28
-
Zhong Lun Advises on Zai Lab’s Secondary Listing in Hong Kong
Zhong Lun Law Firm acted as the issuer’s PRC legal counsel in this offering.
-
- 2020-09-23
-
Zhong Lun Assisted Beijing Konruns Pharmaceutical Co., Ltd. with the Acquisition of NT Pharma International Company Limited
Zhong Lun Law Firm acted for Konruns on this project and provided comprehensive legal services, including advising on the transaction structure from the perspective of the laws of multiple jurisdictions and preparing the cross-border acquisition plan, conducting legal due diligence on the assets of the target company in about 20 jurisdictions, providing legal opinions on the licensing and regulatory issues of drug manufacturing and distribution in Mainland China, Hong Kong and various overseas jurisdictions, preparing, reviewing and negotiating on the transaction documents, advising on outbound remittance of funds from Mainland China and cross border security, and assisting with the completion.
-
- 2020-09-04
-
Zhong Lun Advised on TME’s Notes Offering
Zhong Lun Law Firm acted as the PRC legal counsel to the underwriters.